Celularity Inc. (CELU) Key Metrics
CELU valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $40.6M
- Enterprise value
- $68.3M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 2.1 10-yr median 2.1
- Price / book
- 9.9 10-yr median 3.2
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 0.78
CELU key metrics, 2018–2025
Fiscal year ended December 31, 2025 · U.S. dollarsCELU valuation Price multiples at each fiscal year-end price.
Price / sales+27.4%
1.1
2025 · hover or tap a bar for each year
20182025
Free cash flow yield−32.2 pts
−46.6%
2025 · hover or tap a bar for each year
20182025
CELU returns How much profit the business earns on the capital it uses.
Return on assets−34.6 pts
−76.5%
2025 · hover or tap a bar for each year
20182025
Free cash flow margin−37.8 pts
−49.9%
2025 · hover or tap a bar for each year
20182025
Asset turnover−43.6%
0.22
2025 · hover or tap a bar for each year
20182025
CELU per-share figures Results divided by the shares outstanding at year-end.
Revenue per share−58.1%
$1.04
2025 · hover or tap a bar for each year
20182025
Earnings per share
−$3.59
2025 · hover or tap a bar for each year
20182025
Free cash flow per share
−$0.52
2025 · hover or tap a bar for each year
20182025
Book value per share
−$1.49
2025 · hover or tap a bar for each year
20182025
Dividends per share
$0.23
2025 · hover or tap a bar for each year
20182025
Shares outstanding+16.9%
25.6M
2025 · hover or tap a bar for each year
20182025
CELU financial health Debt, liquidity and how easily interest is covered.
Net debt−$33.4M
$34.7M
2025 · hover or tap a bar for each year
20182025
Current ratio−60.2%
0.15
2025 · hover or tap a bar for each year
20182025
Interest coverage
-9.1
2025 · hover or tap a bar for each year
20182025
Debt / assets−26.5%
0.38
2025 · hover or tap a bar for each year
20182025
CELU efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding+46 days
125 days
2025 · hover or tap a bar for each year
20182025
Days of inventory+36 days
172 days
2025 · hover or tap a bar for each year
20182025
Days payables outstanding+970 days
1,426 days
2025 · hover or tap a bar for each year
20182025
Cash conversion cycle−889 days
-1,129 days
2025 · hover or tap a bar for each year
20182025
Capex / revenue−0.3 pts
0.0%
2025 · hover or tap a bar for each year
20182025
CELU valuation history
Fiscal year-endToday8-year median
CELU returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CELU debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CELU cash returned to shareholders
DividendsBuybacksFree cash flow
CELU price vs earnings per share
Share price at year-endEPS (right axis)
CELU key metrics
2018–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||
| Market capitalization | $28.4M | $45.5M | $47.9M | $193.3M | $651.6M | — | — | — |
| Enterprise value | $63.1M | $113.6M | $47.7M | $244.9M | $645.5M | — | — | — |
| P/E ratio | — | — | — | 13.6 | — | — | — | — |
| Price / sales | 1.1 | 0.8 | 2.1 | 10.8 | 30.5 | — | — | — |
| Price / book | — | 5.2 | 1.2 | 1.0 | 6.6 | — | — | — |
| EV / sales | 2.4 | 2.1 | 2.1 | 13.6 | 30.3 | — | — | — |
| Earnings yield | −323.1% | −127.1% | −409.4% | 7.3% | −15.4% | — | — | — |
| Free cash flow yield | −46.6% | −14.4% | −89.1% | −74.0% | −17.8% | — | — | — |
| Dividend yield | 20.8% | 0.0% | — | 20.2% | — | — | — | — |
| Shareholder yield (dividends + buybacks) | 20.8% | 0.0% | — | 20.3% | 0.0% | — | — | — |
| Share price at fiscal year-end | $1.11 | $2.08 | $2.47 | $12.90 | $51.20 | $110.00 | $99.50 | — |
| Per share | ||||||||
| Revenue per share | $1.04 | $2.48 | $1.18 | $1.20 | $1.68 | — | — | — |
| Earnings per share | −$3.59 | −$2.64 | −$10.13 | $0.95 | −$7.87 | — | — | — |
| Operating cash flow per share | −$0.52 | −$0.29 | −$2.00 | −$9.20 | −$8.65 | — | — | — |
| Free cash flow per share | −$0.52 | −$0.30 | −$2.21 | −$9.55 | −$9.14 | — | — | — |
| Cash per share | $0.24 | $0.03 | $0.01 | $0.93 | $2.93 | — | — | — |
| Book value per share | −$1.49 | $0.40 | $2.11 | $13.28 | $7.81 | — | — | — |
| Tangible book value per share | −$2.08 | −$0.35 | $1.17 | −$2.79 | −$11.56 | — | — | — |
| Dividends per share | $0.23 | $0.00 | — | $2.61 | — | — | — | — |
| Capex per share | $0.00 | $0.01 | $0.21 | $0.35 | $0.49 | — | — | — |
| Debt per share | $1.60 | $3.14 | — | $4.38 | $2.45 | — | — | — |
| Shares outstanding | 25.6M | 21.9M | 19.4M | 15.0M | 12.7M | — | — | — |
| Change in shares outstanding | +16.9% | +13.0% | +29.3% | +17.7% | — | — | — | — |
| Returns & profitability | ||||||||
| Return on equity (ROE) | — | −232.5% | −163.7% | 9.5% | −169.5% | −266.0% | −307.7% | — |
| Return on invested capital (ROIC) | — | −51.5% | −41.5% | −14.9% | −195.0% | — | −302.9% | — |
| Return on assets (ROA) | −76.5% | −41.9% | −72.0% | 3.5% | −23.7% | −43.7% | −81.3% | −4.4% |
| Return on tangible assets | −99.5% | −49.9% | −156.4% | 8.8% | −59.7% | −114.2% | −172.3% | — |
| Free cash flow margin | −49.9% | −12.1% | −187.7% | −796.2% | −545.1% | −637.5% | −5.2% | −10.9% |
| Income quality (OCF / net income) | — | — | — | −9.72 | — | — | — | — |
| Financial health | ||||||||
| Total debt | $40.9M | $68.8M | — | $65.6M | $31.1M | $30.6M | $28.1M | $150,000 |
| Cash & short-term investments | $6.2M | $738,000 | $227,000 | $14.0M | $37.2M | $54.3M | $28.1M | $24,707 |
| Net debt | $34.7M | $68.1M | −$227,000 | $51.6M | −$6.1M | −$23.7M | −$66,000 | $125,293 |
| Debt / equity | — | 7.79 | — | 0.33 | 0.31 | 1.64 | 0.20 | — |
| Debt / assets | 0.38 | 0.52 | — | 0.16 | 0.08 | 0.07 | 0.05 | 6.07 |
| Current ratio | 0.15 | 0.38 | 0.29 | 0.54 | 1.42 | 2.70 | 1.78 | 0.16 |
| Quick ratio | 0.15 | 0.28 | 0.21 | 0.45 | 1.06 | 2.56 | 1.63 | −23.32 |
| Interest coverage | -9.1 | -6.1 | -25.4 | -8.1 | -34.4 | -64.5 | -70.5 | — |
| Working capital | −$68.4M | −$33.1M | −$47.5M | −$28.6M | $11.0M | $45.5M | $16.2M | −$125,848 |
| Invested capital | −$3.3M | $76.9M | $40.7M | $250.5M | $93.3M | −$5.0M | $137.8M | −$554 |
| Tangible asset value | −$53.2M | −$7.8M | $22.6M | −$41.8M | −$147.1M | −$230.0M | −$260.7M | −$524.5M |
| Net current asset value | −$133.1M | −$103.3M | −$83.1M | −$168.7M | −$277.5M | −$340.1M | −$346.8M | −$125,848 |
| Graham number | — | — | — | $16.82 | — | — | — | — |
| Graham net-net per share | −$5.29 | −$5.04 | −$4.76 | −$12.04 | −$21.12 | — | — | — |
| Capital allocation | ||||||||
| Dividends paid | $5.9M | $0 | — | $39.1M | — | — | — | — |
| Share buybacks (net) | — | — | — | $132,000 | $0 | $256,000 | $0 | — |
| Dividend payout ratio | — | — | — | 275.3% | — | — | — | — |
| Capex / revenue | 0.0% | 0.3% | 17.8% | 29.1% | 29.1% | 194.9% | 0.0% | 10.9% |
| Capex / depreciation | 0.00 | 0.02 | 0.43 | 0.55 | 0.70 | 3.41 | 0.00 | 0.40 |
| Stock-based compensation / revenue | 39.1% | 21.3% | 65.9% | 88.2% | 187.5% | 30.6% | 17.3% | 25.6% |
| R&D / revenue | 56.6% | 32.1% | 133.8% | 436.0% | 414.1% | 369.1% | 217.8% | 165.6% |
| SG&A / revenue | 193.1% | 108.2% | 222.1% | 366.4% | 333.2% | 219.5% | 197.6% | — |
| Efficiency | ||||||||
| Days sales outstanding | 125.2 | 79.4 | 136.3 | 123.9 | 100.8 | 123.1 | 60.4 | 81.5 |
| Days of inventory on hand | 171.5 | 135.9 | 126.0 | 137.9 | 253.3 | 262.1 | 195.3 | 196.9 |
| Days payables outstanding | 1,426.2 | 455.9 | 227.4 | 140.4 | 278.1 | 200.1 | 152.6 | 293.3 |
| Cash conversion cycle (days) | -1,129.5 | -240.5 | 35.0 | 121.4 | 76.1 | 185.0 | 103.1 | -15.0 |
| Receivables turnover | 2.92 | 4.59 | 2.68 | 2.95 | 3.62 | 2.97 | 6.04 | 4.48 |
| Payables turnover | 0.26 | 0.80 | 1.61 | 2.60 | 1.31 | 1.82 | 2.39 | 1.24 |
| Inventory turnover | 2.13 | 2.69 | 2.90 | 2.65 | 1.44 | 1.39 | 1.87 | 1.85 |
| Asset turnover | 0.22 | 0.39 | 0.08 | 0.04 | 0.05 | 0.03 | 0.08 | 710.49 |
| Average receivables | $9.1M | $11.8M | $8.5M | $6.1M | $5.9M | $4.8M | $3.5M | $3.9M |
| Average payables | $24.9M | $18.7M | $10.0M | $7.6M | $7.4M | $2.7M | $2.6M | $5.3M |
| Average inventory | $3.0M | $5.6M | $5.5M | $7.4M | $6.7M | $3.5M | $3.4M | $3.5M |
| Intangibles / total assets | 14.1% | 12.5% | 12.8% | 60.0% | 59.5% | 57.7% | 76.4% | 2,122,289.2% |
Computed from CELU's annual financial statements (latest annual report filed April 30, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CELU valuation and financial ratios
It ended the year with $40.9 million of debt and $6.2 million in cash and short-term investments, net debt of $34.7 million. It returned $5.9 million to shareholders: $5.9 million in dividends and $0 in share buybacks.
See the CELU income statement, the CELU chart for price history, or the CELU stock overview for the latest quote and news.
CELU key metrics FAQ
How much debt does Celularity have?
Celularity had total debt of $40.9 million at the end of fiscal 2025.
What is Celularity's dividend yield?
Celularity paid $5.9 million in dividends in fiscal 2025 ($0.23 per share), a payout ratio of —.
What is Celularity's free cash flow yield?
Celularity generated -$13.3 million of free cash flow in fiscal 2025, a free cash flow yield of −46.6% on its market value at year-end ($28.4 million).
What is Celularity's current ratio?
Celularity's current ratio was 0.15 at the end of fiscal 2025: current assets were 0.15 times current liabilities.